Vitro, S.A.B. de C.V.
VITOF
$0.66
-$0.01-1.49%
OTC PK
| 09/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -10.95% | -88.21% | 105.26% | -87.00% | -87.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.95% | -88.21% | 105.26% | -87.00% | -87.00% |
| Cost of Revenue | 2.97% | -91.53% | 103.28% | -91.32% | -91.30% |
| Gross Profit | -25.18% | -78.49% | 114.66% | -73.57% | -73.60% |
| SG&A Expenses | -16.54% | -77.13% | 112.53% | -73.64% | -73.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -136.02% | -- | -91.55% | 2,757.52% | 2,554.87% |
| Total Operating Expenses | -10.97% | -88.70% | 104.17% | -87.33% | -87.35% |
| Operating Income | -10.74% | -80.37% | 156.98% | -81.84% | -81.46% |
| Income Before Tax | -1,242.83% | -23.26% | 14.64% | -123.32% | -126.07% |
| Income Tax Expenses | -77.00% | 72.57% | 165.26% | -103.24% | -103.65% |
| Earnings from Continuing Operations | -1,818.60% | -28.23% | -11.30% | 88.71% | 87.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -56.86% | -- |
| Net Income | -340.13% | -28.33% | 1,462.43% | 190.82% | 188.60% |
| EBIT | -10.74% | -80.37% | 156.98% | -81.84% | -81.46% |
| EBITDA | -78.43% | -85.36% | 372.93% | -37.88% | -37.69% |
| EPS Basic | -333.33% | -30.88% | 1,088.82% | 200.00% | 199.33% |
| Normalized Basic EPS | -1,244.12% | -- | -47.64% | -124.64% | -- |
| EPS Diluted | -333.33% | -30.88% | 1,088.82% | 200.00% | 199.33% |
| Normalized Diluted EPS | -1,244.12% | -- | -47.64% | -124.64% | -- |
| Average Basic Shares Outstanding | 2.91% | 3.66% | -6.99% | -9.18% | -10.76% |
| Average Diluted Shares Outstanding | 2.91% | 3.66% | -6.99% | -9.18% | -10.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |